SCHEMBL892183

SCHEMBL892183

C=CC(CCCCC)OC(C=C)CCCCC

nearest known ligand 0.37

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.37
OPRM1 P35372 1/20 0.37
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.34
DNM1 Q05193 2/20 0.33
ADH1B P00325 1/20 0.33
ADH1C P00326 1/20 0.33
ADH1A P07327 1/20 0.33
ADH4 P08319 1/20 0.33
ADH7 P40394 1/20 0.33
SMPD1 P17405 3/20 0.32
TRPA1 O75762 1/20 0.32
DDAH1 O94760 1/20 0.32
GAPDH P04406 1/20 0.32
MAPT P10636 1/20 0.32
FDPS P14324 1/20 0.32
THRB P10828 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3680596 0.98 TSHR (0.41) TSHROPRM1LMNADNM1ADH1B
SCHEMBL1697082 0.98 TSHR (0.41) TSHROPRM1LMNADNM1ADH1B
SCHEMBL8581070 0.98 TSHR (0.41) TSHROPRM1LMNADNM1ADH1B
SCHEMBL1715275 0.98 TSHR (0.41) TSHROPRM1LMNADNM1ADH1B
SCHEMBL1378622 0.98 TSHR (0.41) TSHROPRM1LMNADNM1ADH1B
SCHEMBL2187237 0.98 TSHR (0.41) TSHROPRM1LMNADNM1ADH1B
SCHEMBL5177427 0.98 TSHR (0.41) TSHROPRM1LMNADNM1ADH1B
SCHEMBL9311248 0.98 TSHR (0.41) TSHROPRM1LMNADNM1ADH1B
SCHEMBL21638858 0.98 TSHR (0.41) TSHROPRM1LMNADNM1ADH1B
SCHEMBL724328 0.98 TSHR (0.41) TSHROPRM1LMNADNM1ADH1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 360 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8049024-B2 Heterogenized rhodium complexes, methods of their synthesis and application as hydrosilylation catalysts ADAM MICKIEWICZ UNIVERSITY (PL) 2011-11-01 US claimed
US-20100048932-A1 New Heterogenized Rhodium Complexes, Methods of their Synthesis and Application as Hydrosilylation Catalysts ADAM MICKIEWICZ UNIVERSITY (PL) 2010-02-25 US claimed
US-20060248655-A1 Stainblocker polymers LANXESS CORPORATION 2006-11-09 US claimed
WO-2004083513-A1 STAINBLOCKER POLYMERS LANXESS CORPORATION (US) 2004-09-30 WO claimed
EP-0787750-B1 Poly(alkylethylene) structural isomers BOREALIS GMBH (AT) 2003-05-14 EP claimed
EP-0722922-B1 Manufacture of linear alpha-olefins INDIAN PETROCHEMICALS CORP LIM (IN) 1999-08-18 EP claimed
EP-0722922-A1 Manufacture of linear alpha-olefins INDIAN PETROCHEMICALS CORPORATION LIMITED (IN) 1996-07-24 EP claimed
EP-0499898-B1 Polymeric diphenyldiamines GOODYEAR TIRE & RUBBER (US) 1996-05-22 EP claimed
EP-0522233-B1 Impact resistant graft copolymers HIMONT INC (US) 1995-06-07 EP claimed
JP-8198780-A None JP disclosed
EP-4711434-A1 REFRIGERANT CYCLE APPARATUS Daikin Industries, Ltd. (JP) 2026-03-18 EP disclosed
EP-4234293-B1 REFRIGERATION CYCLE DEVICE FOR VEHICLE DAIKIN IND LTD (JP) 2025-12-24 EP disclosed
US-20250115796-A1 REFRIGERATION CYCLE APPARATUS DAIKIN INDUSTRIES, LTD. (JP) 2025-04-10 US disclosed
EP-3825383-B1 REFRIGERATION CYCLE DEVICE FOR VEHICLE DAIKIN IND LTD (JP) 2024-11-06 EP disclosed
WO-1995006074-A1 WATER-SOLUBLE COPOLYMERIZATES CONTAINING CARBOXYL GROUPS, METHODS OF PRODUCING SAID COPOLYMERIZATES, AND USE THEREOF AS SCALE INHIBITORS BASF AKTIENGESELLSCHAFT (DE) 1995-03-02 WO disclosed
US-5254425-A Macromonomer FUJI PHOTO FILM CO., LTD. (JP) 1993-10-19 US disclosed
EP-0213290-B1 PROCESS FOR THE PREPARATION OF N-ALPHA-ALKOXY-ETHYL FORMAMIDES BASF Aktiengesellschaft (DE) 1988-09-07 EP disclosed
EP-0213290-A1 Process for the preparation of N-alpha-alkoxy-ethyl formamides BASF Aktiengesellschaft (DE) 1987-03-11 EP disclosed
US-4079042-A ANTISTATIC, FABRIC SOFTENERS, BINDERS, PAPER SIZING, HAIR LACQUERS CIBA-GEIGY CORPORATION (US) 1978-03-14 US disclosed
US-3932573-A Process for producing glass fiber reinforced injection molding compounds ETHYL CORPORATION (US) 1976-01-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048932-A1 New Heterogenized Rhodium Complexes, Methods of their Synthesis and Application as Hydrosilylation Catalysts SQLE, HAO2, IPO11 TSHR 3500/4885OPRM1 1493/4885ALDH1A1 1166/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.